419
Views
17
CrossRef citations to date
0
Altmetric
Review

Diagnosing COPD: advances in training and practice – a systematic review

, , &
Pages 219-231 | Published online: 04 Apr 2016

References

  • Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [updated January, 2014] Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdfAccessed September 30, 2015
  • AnonCTerminology, definitions, and classification of chronic pulmonary emphysema and related conditions: a report of the conclusions of a Ciba guest symposiumThorax195914286299
  • CorhayJLPersonalized medicine: chronic obstructive pulmonary disease treatmentRev Med Liege2015705–631031526285458
  • AnderssonMStridsmanCRönmarkELindbergAEmtnerMPhysical activity and fatigue in chronic obstructive pulmonary disease – a population based studyRespir Med201510981048105726070272
  • LiuYPleasantsRCroftJSmoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking historyInt J Chron Obstruct Pulmon Dis2015101409141626229460
  • World Health Organisation [webpage on the Internet]Chronic Obstructive Pulmonary Disease (COPD) [updated October, 2013] Available from: http://www.who.int/respiratory/copd/en/Accessed August 2, 2015
  • MenezesAMJardimJRPérez-PadillaRPrevalence of chronic obstructive pulmonary disease and associated factors: the PLA-TINO Study in Sao Paulo, BrazilCad Saude Publica20052151565157316158163
  • RycroftCEHeyesALanzaLBeckerKEpidemiology of chronic obstructive pulmonary disease: a literature reviewInt J Chron Obstruct Pulmon Dis2012745749422927753
  • BuistASMcBurnieMAVollmerWMBOLD Collaborative Research GroupInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
  • KojimaSSakakibaraHMotaniSIncidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese populationJ Epidemiol2007172546017420613
  • de MarcoRAccordiniSMarconAEuropean Community Respiratory Health Survey (ECRHS)Risk factors for chronic obstructive pulmonary disease in a European cohort of young adultsAm J Respir Crit Care Med2011183789189720935112
  • MoreiraGLGazzottiMRManzanoBMIncidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence studySao Paulo Med J2015133324525126176929
  • KoblizekVZigmondJPecenLImplementation of COPD Phenotypes in Real LifeThematic Poster Session. European Respiratory Society Congress 2015Amsterdam, the Netherlands
  • Torres-DuqueCMaldonadoDPérez-PadillaRForum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass ExposureBiomass fuels and respiratory diseases: a review of the evidenceProc Am Thorac Soc20085557759018625750
  • HnizdoESullivanPABangKMWagnerGAssociation between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination SurveyAm J Epidemiol2002156873874612370162
  • AryalSDiaz-GuzmanEManninoDMInfluence of sex on chronic obstructive pulmonary disease risk and treatment outcomesInt J Chron Obstruct Pulmon Dis201491145115425342899
  • MiravitllesMSoler-CataluñaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450suppl 111624507959
  • QaseemAWiltTJWeinbergerSEAmerican College of PhysiciansAmerican College of Chest PhysiciansAmerican Thoracic SocietyEuropean Respiratory SocietyDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
  • CelliBCoteCMarinJThe body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
  • CelliBUpdate on the management of COPDChest20081331451146218574288
  • O’DonnellDFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
  • StridsmanCLindbergASkärLFatigue in chronic obstructive pulmonary disease: a qualitative study of people’s experiencesScand J Caring Sci20142813013823517049
  • KarpmanCBenzoRGait speed as a measure of functional status in COPD patientsInt J Chron Obstruct Pulmon Dis201491315132025473277
  • KoblizekVTomsovaMCermakovaEImpairment of nasal mucociliary clearance in former smokers with stable chronic obstructive pulmonary disease relates to the presence of a chronic bronchitis phenotypeRhinology20114939740621991564
  • ArikanHSavciSCalik-KutukcuEThe relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPDInt J Chron Obstruct Pulmon Dis2015101829183526379433
  • MatkovicZMiravitllesMChronic bronchial infection in COPD. Is there an infective phenotype?Respir Med20131071102223218452
  • HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • WiseRAAnzuetoACottonDTIOSPIR InvestigatorsTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med20133691491150123992515
  • CazzolaMMacNeeWMartinezFJAmerican Thoracic Society; European Respiratory Society Task Force on outcomes of COPDOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J20083141646918238951
  • MolenTMiravitllesMKocksJCOPD management: role of symptom assessment in routine clinical practiceInt J Chron Obstruct Pulmon Dis2013846147124143085
  • HanMMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med20131435024321803
  • YawnBDuvallKPeabodyJThe impact of screening tools on diagnosis of chronic obstructive pulmonary disease in primary careAm J Prev Med20144756357525241196
  • JonesRPriceDRyanDRespiratory Effectiveness GroupOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortLancet Respir Med2014226727624717623
  • LangePMarottJVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med201218697598122997207
  • ChenCZOuCYYuCHYangSCChangHYHsiueTRComparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary diseaseJ Am Geriatr Soc20156324425025641518
  • Sanchez-SalcedoPBertoJde-TorresJLung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP)Arch Bronconeumol201551416917625641356
  • KoblizekVPecenLZatloukalJReal-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatmentPLoS One20149e11107825380287
  • McGarveyLLeeAJRobertsJGruffydd-JonesKMcKnightEHaughneyJCharacterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care populationRespir Med201510922823725613107
  • CasanovaCMarinJMartinez-GonzalezCCOPD History Assessment In SpaiN (CHAIN) Cohort. New GOLD classification: longitudinal data on group assignmentRespir Res201415324417879
  • JonesPAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classificationEur Respir J20134264765423258783
  • CasanovaCMarinJMMartinez-GonzalezCCOPD History Assessment in Spain (CHAIN) Cohort Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPDChest2015148115916825612228
  • KoblizekVChlumskyJZindrVGOLD and Phenotypes: The New Czech COPD Guidelines. Thematic Poster SessionEuropean Respiratory Society Congress2015Amsterdam, the Netherlands
  • BakkePRönmarkEEaganTRecommendations for epidemiological studies on COPDEur Respir J2011381261127722130763
  • AgustiAThe path to personalised medicine in COPDThorax20146985786424781218
  • VestboJCOPD: definition and phenotypesClin Chest Med2014351624507832
  • Izquierdo-AlonsoJRodriguez-GonzálezmoroJde Lucas-RamosPPrevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD)Respir Med201310772473123419828
  • MiravitllesMCalleMSoler-CataluñaJClinical phenotypes of COPD. Identification, definition and implications for guidelinesArch Bronconeumol201248869822196477
  • National Institute for Health and Care Excellence [webpage on the Internet]Chronic Obstructive Pulmonary Disease (updated) Clinical Guidelines CG101 Available from: http://www.nice.org.uk/CG101Accessed February 19, 2015
  • KankaanrantaHHarjuTKilpeläinenMDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelinesBasic Clin Pharmacol Toxicol201511629130725515181
  • GuptaDAgarwalRAggarwalAS. K. Jindal for the COPD Guidelines Working Group. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint ICS/NCCP (I) recommendationsLung India20133022826724049265
  • KhanJLababidiHAl-MoamaryMThe Saudi guidelines for the diagnosis and management of COPDAnn Thorac Med20149557624791168
  • KoblizekVChlumskyJZindrVCzech Pneumological and Phthisiological SocietyChronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub201315718920123733084
  • Soler-CataluñaJCosíoBIzquierdoJConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol20124833133722341911
  • MontuschiPMalerbaMSantiniGMiravitllesMPharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotypingDrug Discov Today2014191928193525182512
  • LlordésMJaénAAlmagroPPrevalence, risk factors and diagnostic accuracy of COPD among smokers in primary careCOPD201512440441225474184
  • LamprechtBSorianoJStudnickaMBOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study GroupBOLD Collaborative Research Group the EPI-SCAN Team the PLATINO Team and the PREPOCOL Study GroupDeterminants of Underdiagnosis of COPD in national and international surveysChest2015148497198525950276
  • CastilloDBurgosFGuaytaRFARMAEPOC groupAirflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosisRespir Med2015109447548225754101
  • ZhangJZhouJBLinXFWangQBaiCXHongQYPrevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer populationRespirology201318229730223051099
  • LangsetmoLPlattRErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med200817739640118048806
  • XuWColletJShapiroSNegative impacts of unreported COPD exacerbations on health-related quality of life at 1 yearEur Respir J2010351022103019897555
  • MackayAJDonaldsonGCPatelARJonesPWHurstJRWedzichaJAUsefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbationsAm J Respir Crit Care Med20121851218122422281834
  • LeidyNKMurrayLTPatient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RSCOPD20131039339823713600
  • HuntTMadiganSWilliamsMTOldsTSUse of time in people with chronic obstructive pulmonary disease – a systematic reviewInt J Chron Obstruct Pulmon Dis201491377138825548519
  • AlmagroPLapuenteAYunSUnderdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective studyInt J Chron Obstruct Pulmon Dis2015101353136126213464
  • JairamPMvan der GraafYLammersJWMaliWPde JongPAPROVIDI Study groupIncidental findings on chest CT imaging are associated with increased COPD exacerbations and mortalityThorax20157072573126024687
  • IncalziRAScarlataSPennazzaGSantonicoMPedoneCChronic obstructive pulmonary disease in the elderlyEur J Intern Med201425432032824183233
  • CaiSQinLTanoueLEffects of one-hour training course and spirometry on the ability of physicians to diagnose and treat chronic obstructive pulmonary diseasePLoS One2015102e011734825706774
  • SchünenmannHWoodheadMAnzuetoAATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline DevelopmentA guide to guidelines for professional societies and other developers of recommendations. Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop reportProc Am Thorac Soc20129521521823256161
  • SarcIJericTZiherlKAdherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary diseaseJ Eval Clin Pract20111743743
  • WhitePThortonHPinnockHGeorgopoulouSBoothHPOver-treatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
  • LucasASmeenkFSmeeleIvan SchayckCOvertreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory studyFam Pract2008252869118304973
  • RocheNPribilCvan GanseEReal-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational studyBMC Pulm Med20141415624694050
  • ZbozinkovaZBarczykATkacovaRPOPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern EuropeInt J Chron Obstruct Pulmon Dis2016
  • FosterJAYawnBPMaziarAJenkinsTRennardSICasebeerLEnhancing COPD management in primary care settingsMedGenMed2007932418092030
  • PeabodyJLuckJDeMariaLMenonRQuality of care and health status in UkraineBMC Health Serv Res20141444625269470
  • LaubeBJanssensHde JonghFEuropean Respiratory Society; International Society for Aerosols in MedicineWhat the pulmonary specialist should know about the new inhalation therapiesEur Respir J20113761308133121310878
  • LeungJBhutaniMLeighRPelletierDGoodCSinDDEmpowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthmaCan Respir J201522526627026436910
  • HaroonSJordanRTakwoingiYAdabPDiagnostic accuracy of screening tests for COPD: a systematic review and meta-analysisBMJ Open2015510e008133
  • PietinalhoAKinnulaVSovijärviAChronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim reportRespir Med200710171419142517353122
  • EatonTWithySGarrettJEMercerJWhitlockRMReaHHSpirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshopsChest199911641642310453871
  • ZwarNAMarksGBHermizOPredictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practiceMed J Aust2011195416817121843115
  • HillKGoldsteinRSGuyattGHPrevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary careCMAJ2010182767367820371646
  • RobertsCMAbediMKABarryJSPredictive value of primary care made clinical diagnosis of chronic obstructive pulmonary disease (COPD) with secondary care specialist diagnosis based on spirometry performed in a lung function laboratoryPrim Health Care Res Dev20091049
  • BednarekMMaciejewskiJWozniakMPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax200863540240718234906